Login / Signup

Efficacy and Safety of Modified Yupingfeng Nasal Spray in Controlling the Recurrence of Persistent and Moderate-Severe Allergic Rhinitis: Study Protocol for a Multicenter, Open-Label, Randomized, and Parallel-Arm Trial.

Ting LiuBing-Qing LuDan-Dan WangChao LiaoHan-Jen ChiangRong ZhangYuan XiLi Tian
Published in: Evidence-based complementary and alternative medicine : eCAM (2022)
. This study was registered with registration number ChiCTR2100047053 (Chinese Clinical Trial Registry, https://www.chictr.org.cn/showproj.aspx?proj=127432 on June 7, 2021).
Keyphrases
  • open label
  • phase iii
  • phase ii
  • clinical trial
  • double blind
  • allergic rhinitis
  • study protocol
  • placebo controlled
  • phase ii study
  • lymph node metastasis
  • high intensity
  • squamous cell carcinoma
  • chronic rhinosinusitis